Skip to main content
Fig. 3 | BMC Palliative Care

Fig. 3

From: Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial

Fig. 3

Cost-effectiveness planes of costs (health care costs, public transfers and costs of intervention) per QALY. Note: ICER: incremental cost-effectiveness ratio. QALY: quality adjusted life year. Based on 1000 bootstrap replications. a total costs 2013–2016 excluding home care services, b total costs 2013–2016 excluding home care services and cost of intervention, c total costs 2013 – June 2015, d total costs 2013 – June 2015 excluding cost of intervention

Back to article page
\